Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
July, 2026
July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Archil Jaliashvili: Hemopure and the Future of Oxygen Delivery in Severe Bleeding
Archil Jaliashvili/LinkedIn
May 20, 2026, 15:47

Archil Jaliashvili: Hemopure and the Future of Oxygen Delivery in Severe Bleeding

Archil Jaliashvili, Co-owner, General Manager of SkinAI, Co-Chief Executive Officer at GeoBio Pharm, shared a post on LinkedIn:

”A patient with catastrophic hemorrhage survived after Cleveland Clinic used Hemopure, when conventional blood transfusion was not an option.

For decades, we spoke about ‘blood substitutes.’

But the real medical target was never blood itself.

The target is oxygen delivery.

We should not only manage hemoglobin numbers.

We must manage tissue oxygenation.

The future of transfusion medicine will not be only about blood.

It will be about precision oxygen delivery.

For emerging BHOC biological hemoglobin oxygen carrier biosimilar and new-generation platforms, this is another important real-world signal that the field is evolving toward solving major global unmet medical needs:

  • Severe hemorrhage
  • Trauma and emergency care
  • Battlefield medicine
  • Maternal bleeding
  • Organ preservation and perfusion
  • Veterinary critical care
  • Remote and disaster medicine

Sometimes one clinical case says more than a thousand theoretical discussions.”

Stay updated with Hemostasis Today.

Archil Jaliashvili Health Hematology Hemopure Hemostasis News Hemostasis Today Medicine
NewsFeed